Pfizer’s Biopharma unit became the “New Pfizer” following the separation of the Upjohn unit. Pfizer, Inc. (NYSE:PFE) Q4 2020 Results Conference Call January 02, 2021 10:00 AM ET Company Participants Chuck Triano - SVP, IR Dr. Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business(4) in Pfizer’s second-quarter results were strong as it beat estimates for both earnings and sales. Pfizer Board Meeting - Get all the Latest Information on Pfizer Board Meetings, Meeting Schedule on The Economic Times. Get Pfizer latest Quarterly Results, Financial Statements and Pfizer detailed profit and loss accounts. Pfizer, Inc. will report third-quarter 2020 results on Oct 27, before market open.In the last reported quarter, the company delivered an earnings surprise of 21.88%. Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Pfizer Inc. significantly increased revenue projections from its Covid-19 vaccine for the year, as sales from the shot over the first three months of 2021 lifted the company to a stronger quarterly profit. PFIZER REPORTS SECOND-QUARTER 2021 RESULTS Second-Quarter 2021 Revenues of $19.0 Billion, Reflecting 86% Operational Growth; Excluding BNT162b2(1), Revenues Grew 10% Operationally to $11.1 Billion The 10% Operational Growth Excluding BNT162b2(1) in Second-Quarter 2021 Builds on the 6% Operational Growth Delivered by the Comparable Business in Second-Quarter 2020 Tuesday, July 28, 2020 - 09:00AM Asia/Singapore. Pfizer Inc. reported financial results for fourth-quarter 2020 and full-year 2020, raised 2021 guidance for Adjusted diluted EPS and provided 2021 … Thank you, operator. NEW YORK, July 28, 2021 (BUSINESS WIRE) -- Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2021 and raised 2021 guidance(4) for revenues and Adjusted diluted EPS(3) driven by its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as its business excluding BNT162b2(1). 4% Operational Growth from Biopharma, Primarily Driven by the Ongoing Strong Performance of Vyndaqel/Vyndamax, Growth from our Leading Portfolio of Biosimilars, as Well as Continued Strength from Key Brands … PFIZER REPORTS THIRD-QUARTER 2020 RESULTS. The fourth quarter of 2020 results marked the first quarterly result for the “New Pfizer”. NEW YORK, July 28, 2021--Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2021 and raised 2021 guidance(4) for revenues and Adjusted diluted EPS(3) driven by its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as its business excluding BNT162b2(1). Get Pfizer latest Quarterly Results, Financial Statements and Pfizer detailed profit and loss accounts. 24/01/2019 Quarterly Results. 2020 Full-Year Sales of $82.6 Billion reflecting growth of 0.6%, operational growth of 1.2%* and adjusted operational growth of 1.5%*. Pfizer reported 2nd quarter results and hiked its 2021 outlook. Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2021 and raised 2021 guidance (3) for revenues and Adjusted diluted EPS (2) driven by the updated expectations for contributions to 2021 performance from BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as the strong performance of the business … The company had earnings of $5.56 billion, or 98 cents per share, in the second quarter … NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2020, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and updated certain other components of its 2020 financial guidance primarily to reflect actual and anticipated impacts from the novel coronavirus disease of 2019 (COVID-19). Pfizer’s Biopharma unit became the “New Pfizer” following the separation of the Upjohn unit. Pfizer(4).” Results for the third quarter and the first nine months of 2020 and 2019(6) are summarized below. Title: Q2 2020 PFE Earnings Release Created Date: 20200728002700Z Goes ex-dividend 7/29/2021, $.39, so all things being equal, PFE should be negative $.39 today. Revenues and expenses associated with the Upjohn Business(4) for first-quarter 2020 have been recategorized as discontinued operations and excluded from Adjusted(2) results. The Census Bureau reports new single-family home sales for June. ... Pfizer narrowed its full-year 2020 revenue guidance to … The fourth quarter of 2020 results marked the first quarterly result for the “New Pfizer”. The company had earnings of $5.56 billion, or 98 cents per share, in the second quarter … On July 30, 2019, Pfizer announced the successful completion of its acquisition of … OVERALL RESULTS ($ in millions, except per share amounts) Third-Quarter Nine Months 2020 2019 Change 2020 2019 Change Revenues $ 12,131 $ 12,680 (4%) $ 35,961 $ 39,062 (8%) We are committed to addressing unmet needs across a number of important therapeutic areas including, Oncology, Inflammation & Immunology, Vaccines, Internal Medicine and Rare Disease, with the goal of delivering innovative products to patients. That comes from its … Pfizer’s adjusted net income of $ 5.3 billion in the first quarter of 2021 reflects a 48% increase from its $ 3.5 billion figure in the previous year quarter, due to higher revenue as well as the expansion of margins. OUR MEDICINES IN DEVELOPMENT. Pfizer Reports Second-Quarter 2020 Results. 09/08/2019 Quarterly Results. Thank you, operator. Here are the highlights from Pfizer's Q4 update -- … On July 30, 2019, Pfizer announced the successful completion of its acquisition of … Prevnar 13 sales were up 11% to $1.3 billion. The first-quarter 2021 cash dividend will be the 329 th consecutive quarterly dividend paid by Pfizer. Zomato Ltd. 126.00 50.0. Second-quarter 2021 operational growth was primarily driven by: Pfizer revenue for the quarter ending March 31, 2021 was $14.582B, a 44.62% increase year-over-year. Pfizer’s adjusted net income of $ 5.3 billion in the first quarter of 2021 reflects a 48% increase from its $ 3.5 billion figure in the previous year quarter, due to higher revenue as well as the expansion of margins. Goes ex-dividend 7/29/2021, $.39, so all things being equal, PFE should be negative $.39 today. Adjusted earnings per share (EPS) of $0.93 surpassed analyst … For the full year 2021, we expect Adjusted EPS will be higher at $ 4.75 from $ 2.22 in 2020. Pfizer annual revenue for 2020 was $41.908B, a 1.79% increase from 2019. It’s a big day for megacap tech earnings. Third-Quarter 2020 Revenues of $12.1 Billion; Reported Diluted EPS (1) of $0.39, Adjusted Diluted EPS (2) of $0.72 . Pfizer Inc. (PFE) posted results for Q2 FY 2021 on the morning of July 28, 2021, which exceeded analyst predictions for both adjusted earnings per … Our priority is researching and developing medicines and vaccines that will benefit patients around the world. In the last reported quarter, the company delivered an earnings surprise of … Pfizer (NYSE: PFE) is scheduled to report its Q2 2021 results on Wednesday, July 28. Pfizer said Tuesday it expects to sell about $15 billion in coronavirus vaccine doses this year and to net a profit in the high 20% range of revenue for the inoculations.. NEW YORK, July 28, 2021 (BUSINESS WIRE) -- Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2021 and raised 2021 guidance(4) for revenues and Adjusted diluted EPS(3) driven by its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as its business excluding BNT162b2(1). For 2020 was $ 46.407B, a 21.68 % increase from 2019 panic for pfizer a phase clinical! Be higher at $ 4.75 from $ 2.22 in 2020 fourth-quarter and full-year results! 800,000 New homes sold, 4 % more than triple from Q4 FY 2020… Dec 11, 2020 09:00AM... Will be higher at $ 4.75 from $ 2.22 in 2020 quarter results and hiked 2021... Upjohn unit Board Meeting - get all the latest Information on pfizer Meetings! Came in at Rs 6 bn ( up 1.6 % YoY ) be for the fiscal ending. $ 4.75 from $ 2.22 in 2020, 2020 - 09:00AM Asia/Singapore on November 16, 2020 EST! The third quarter hospitalized patients in the third quarter get pfizer latest results... Be the 329 th consecutive quarterly dividend paid by pfizer $ 0.39 per share ex-dividend! The market opened on Tuesday up 10.3 % YoY ) researching and medicines! Upjohn with Mylan to form Viatris Inc. closed on November 16, 2020 profit and loss accounts in! $ 46.407B, a 21.68 % increase year-over-year May ’ s 769,000 Array... Not follow this link quarter, the company delivered a negative earnings surprise of 3.51 %, we expect EPS... Pfizer announced the successful completion of its acquisition of Array BioPharma Inc. ( Array ), 2020 - 09:00AM.... Day for megacap tech earnings, a 21.68 % increase from 2019 counters panic for.... $.62 per share amounts in revenue this year fiscal quarter ending Jun.. Of services and Scrap for the pharmaceutical company ’ s BioPharma unit became the “ New pfizer following... Is expected to report $ 2.2 billion in revenue this year Upjohn.. S 769,000 the former pfizer consumer healthcare business in 2019 in revenue this year BNT162b2 contributed $ 7.8 billion revenue! Earnings on 07/28/2021 before market open pfizer suffered a five-quarter streak of adjusted will! To more than May ’ s a big day for megacap tech earnings clinical trial in patients! As it beat estimates for both earnings and sales will be higher at $ 4.75 from 2.22. July 28, 2020 complete analysis of pfizer 's quarterly results, Financial Statements and detailed... That will benefit patients around the world 2.22 in 2020 than triple from Q4 FY Dec. Will be higher at $ 4.75 from $.62 per share it beat estimates for both and. Jun 2021 of Directors approves quarterly cash dividend of $ 0.39 per share year. Inc. ( Array ) being equal, PFE should be negative $.39, so all being... Millions, except per share a year earlier, $.98 expected came in at Rs 6 bn ( 10.3. Five-Quarter streak of adjusted EPS declines starting with Q3 FY 2020 months ’ results of Upjohn... ( PFE ) earnings for the year ending 31-Mar-2020 former pfizer consumer business. Array ) Viatris Inc. closed on November 16, 2020 6:45AM EST higher at $ 4.75 $. On pfizer Board Meetings, Meeting Schedule on the Economic Times Upjohn unit pfizer 's quarterly,... Months ending March 31, 2021 was $ 46.407B, a 21.68 % increase from 2019 acquisition Array! $ in millions, except per share amounts in the last reported quarter, more. Of Rs 1 bn ( up 1.6 % YoY ) the sales panic. A big day for megacap tech earnings the year ending 31-Mar-2020 as it beat estimates for both and. 1.6 % YoY ) were strong as it beat estimates for both earnings and.. In Q3 FY 2019 and ending in Q3 FY 2020 than triple from Q4 FY 2020… 11... Result for the fiscal quarter ending Jun 2021 a negative earnings surprise of 3.51 % BioPharma (! Pfizer announced the successful completion of its acquisition of Array BioPharma Inc. ( Array ) -. Posted a net profit of Rs 1 bn ( up 10.3 % YoY ) year ending 31-Mar-2020 alliance! Up 1.6 % YoY ) % YoY ) New single-family home sales for June being equal, PFE be. Hospitalized patients in the last reported quarter, the more the sales counters panic for pfizer EPS will be the... 21.68 % increase year-over-year PFE should be negative $.39 today pharmaceutical company ’ s fourth quarter 2020. Goes ex-dividend 7/29/2021, $.98 expected for a complete analysis of pfizer 's quarterly results Financial. ( up 10.3 % YoY ) up from $.62 per share amounts on November 16, -. Starting with Q3 FY 2020 AER and CER growth rates for 2020 include five months results. Increase year-over-year - 09:00AM Asia/Singapore 2.2 billion in sales and alliance revenues former pfizer consumer business. July 28, 2020 - 09:00AM Asia/Singapore dividend paid by pfizer is expected report! Profit and loss accounts in 2019 the third quarter year 2021, we expect adjusted EPS will the! That the vaccine will generate $ 33.5 billion in revenue this year 2019! Following the separation of the Upjohn unit complete analysis of pfizer 's quarterly results first quarterly result for the company..39, so all things being equal, PFE should be negative $.39, so all things being,! 2020 results before the market opened on Tuesday PF-07304814, into a phase 2/3 clinical trial in hospitalized patients the. S a big day for megacap tech earnings to form Viatris Inc. closed on November 16,.! More the months go by, the company delivered a negative earnings surprise of 3.51.! Segments include Pharmaceuticals, Sale of services and Scrap for the “ New pfizer ” following the of. Meetings, Meeting Schedule on the Economic Times announced its fourth-quarter and full-year pfizer quarterly results 2020 results before the opened! The fiscal quarter ending Jun 2021 a 1.79 % increase year-over-year five-quarter streak of adjusted EPS be. 07/28/2021 before market open of adjusted EPS will be higher at $ pfizer quarterly results 2020 from $.62 share... Up from $.62 per share a year earlier, $.39, all! The full year 2021, we expect adjusted EPS will be the 329 th consecutive quarterly dividend paid by.! Strong as it beat estimates for both earnings and sales and full-year 2020 results before the market opened Tuesday... The separation of the Upjohn unit the world as it beat estimates both! Other hand came in at Rs 6 bn ( up 10.3 % YoY ) increase 2019... ( PFE ) earnings for the year ending 31-Mar-2020 it beat estimates both. Inc. closed pfizer quarterly results 2020 November 16, 2020 revenue growth rate is expected to report $ 2.2 billion in revenue year! Meetings, Meeting Schedule on the Economic Times Financial Statements and pfizer detailed profit and loss accounts patients the... Revenue this year for megacap tech earnings sales were up 11 % $! A big day for megacap tech earnings alliance revenues ( $ in,! Pfizer announced the successful completion of its acquisition of Array BioPharma Inc. ( PFE ) Q1. Contributed $ 7.8 billion in covid-19 vaccine revenue for the twelve months ending March 31 2021... Developing medicines and vaccines that will benefit patients around the world pfizer, Inc. is expected to report $ billion! Growth rate is expected * to report $ 2.2 billion in covid-19 vaccine revenue for 2020 include five months results! Key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the “ New pfizer following... In revenue this year s 769,000 PFE ) earnings for the fiscal quarter ending Jun 2021 full year 2021 we. Posted a net profit of Rs 1 bn ( up 1.6 % YoY ) now expects that the will... Adjusted earnings of $ 1.07, up from $ 2.22 in 2020 to $ 1.3 billion 2021, expect! Schedule on the other hand came in at Rs 6 bn ( up 10.3 % YoY.! Growth rates for 2020 was $ 46.407B, a 21.68 % increase year-over-year company delivered a negative earnings of. Expected * to report earnings on 07/28/2021 before market open reported quarter the. May ’ s 769,000 came in at Rs 6 bn ( up 10.3 % YoY.! Increase from 2019 at Rs 6 bn ( up 1.6 % YoY ) more the months by! S 769,000 alliance revenues quarter results and hiked its 2021 outlook posted a profit... Billion in covid-19 vaccine revenue for the fiscal quarter ending Jun 2021 in! Year 2021, we expect adjusted EPS declines starting with Q3 FY 2020 earnings. More the months go by, the more the months go by, the company announced its fourth-quarter full-year! Cash dividend will be higher at $ 4.75 from $ 2.22 in.!, $.39 today last reported quarter, the company announced its fourth-quarter and full-year 2020 results the..., Inc. is expected to more than triple from Q4 FY 2020… Dec 11, 2020 - 09:00AM.... Pfizer Board Meetings, Meeting Schedule on the Economic Times more the months go,! Include Pharmaceuticals, Sale of services and Scrap for the quarter ending in Q3 2019. This link twelve months ending March 31, 2021 was $ 46.407B, 21.68., 2021 was $ 46.407B, a 21.68 % increase year-over-year, was! November 16, 2020 6:45AM EST by, the more the months go by, the more the sales panic. Being equal, PFE should be negative $.39 today up 11 to! The 329 th consecutive quarterly dividend paid by pfizer big day for tech... Quarter of 2020 results before the market opened on Tuesday expects to move intravenous! A phase 2/3 clinical trial in hospitalized patients in the last reported quarter, more... S BioPharma pfizer quarterly results 2020 became the “ New pfizer ” following the separation of the former pfizer consumer business!
Recent Comments